HIV and AIDS in the People's Republic of China: A collaborative review

International Journal of STD and AIDS

Volumn 14, Issue 11, 2003, Pages 757-761

  Portsmouth, Simon ^a,c   Stebbing, Justin ^a   Keyi, Xu ^b   Jianping, Zhang ^b   Guohua, Pi ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b PEKING UNIVERSITY   (China)

^c NONE   (United Kingdom)

Author keywords

AIDS; Anti retrovirals; China; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; CHINESE DRUG; CHLOROQUINE; DIDANOSINE; EFAVIRENZ; HERBACEOUS AGENT; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CHINA; CHINESE MEDICINE; DRUG COST; EPIDEMIC; HEALTH PROMOTION; HERBAL MEDICINE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PRIORITY JOURNAL; REVIEW; UNITED NATIONS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHINA; DELIVERY OF HEALTH CARE; DRUGS, CHINESE HERBAL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS;

EID: 0242606214     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/09564620360719804     Document Type: Review

References (28)

1. Kaufman J, Jing J. China and AIDS - the time to act is now. Science 2002;296:2339-40
2. Chuan Q. State ups the ante in war on AIDS. China Daily 2001. Report on the first China AIDS/STD conference, 13-16 November 2002, Beijing
3. Zhang K-L, Ma S-J. Epidemiology of HIV in China. BMJ 2002;324:803-4
4. Tomlinson R. China steps up battle against AIDS. BMJ 1996;312:1056
5. Liao S, Choi KH, Zhang K, et al. Extremely low awareness of AIDS, sexually transmitted diseases and condoms among Dai ethnic villagers in Yunnan province, China. AIDS 1997;11(Suppl 1):S27-34
6. Wu Z, Detels R, Zhang J, et al. Risk factors for intravenous drug use and sharing equipment among young male drug users in Longchuan county, south-west China. AIDS 1996;10:1017-24
7. Zheng X, Zhang J, Wang X, et al. The natural history of HIV infection among IDUs in Ruili, Yunnan province, China. Zhoghua Liu Xing Bing Xue Za Zhi 2000;21:17-18
8. Su L, Graf M, Zhang Y, et al. Characterization of a virtually full length human immunodeficiency virus type 1 genome of a prevalent inter sub-type (C/B′) recombinant strain in China. J Virol 2000;74:11367-76
9. Chen J, Zheng Z, Shao Y. Molecular-epidemiological analysis of HIV-1 initial prevalence in Guangxi, China. Zhoghua Liu Xing Bing Xue Za Zhi 1999;20:74-7
10. Cohen M, Ping G, Fox K, et al. Sexually transmitted diseases in the People's Republic of China in Y2K. Sex Transm Dis 2000;27:143-5
11. Sidel VW. The barefoot doctors of the People's Republic of China. N Engl J Med 1972;286:1292-300
12. Hu CK, Ge Y, Chen ST, et al. Ten years of accomplishments in dermatology and venereology. Clin J Dermatol 1959;7:290-4
13. Hu CK, Ge Y, Chen ST. Control and eradication of syphilis in China. Beijing Science Conference 1964;126:167-77
14. Beyre C, Razak MH, Lisan K, et al. Overland heroin traffiking routes and HIV-1 spread in south and south-east Asia. AIDS 2000;14:75-83
15. Zhang C, Yang R, Wia X, et al. High prevalence of HIV-1 and hepatitis C virus co-infection among injection drug users in the southeastern region of Yunnan, China. J Acquir Immune Defic Syndr 2002;29:191-6
16. Cohen MS, Henderson GE, Aiello P, et al. Successful eradication of sexually transmitted diseases in the People's Republic of China: implications for the 21st century. J Infect Dis 1996;174:(Suppl 2):S223-9
17. Neild P, Gazzard B. HIV-1 infection in China. Lancet 1997;350:963
18. Chinese Ministry of Health, UN theme group on HIV/AIDS in China. China responds to AIDS - HIV/AIDS Situation and Needs Assessment Report. Beijing: Chinese Ministry of Health, 1997
19. Wang YG. AIDS, policy and bioethics: ethical dilemmas facing China in HIV prevention: a report from China. Bioethics 1997;11:323-7
20. Novitsky V, Smith UR, Gilbert P, et al. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol 2002;76:5435-51
21. Friman G, Wesslen L. Special feature for the Olympics: effects of exercise on the immune system: infections and exercise in high-performance athletes. Immunol Cell Biol 2000;78:510-22
22. Rosenthal E. Doctors' dirty needles spread hepatitis in China. New York Times, August 2001
23. Savada D, Ahn J, Zhan M, et al. Effects of four Chinese herbal extracts on drug-sensitive and multidrug resistant small cell lung carcinoma cells. Cancer Chemother Pharmacol 2002;49:261-6
24. Kessler DA. Cancer and herbs. N Engl J Med 2000;342:1742-5
25. Paton NI, Aboulhab J, Karim F. Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1. Lancet 2002;359:1667-8
26. Lopes M, Cotta-Ramusino C, Pellicioli A, et al. The DNA replication checkpoint response stabilizes stalled replication forks. Nature 2001;412:557-61
27. Xinha S, Junhua N, Qili G. AIDS and HIV infection in China. AIDS 1994;8(Suppl 2):S55-59
28. Ma S, Dukers NHTM, van den Hoek A, et al. Decreasing STD incidence and increasing condom use among Chinese sex workers following a short term intervention: a prospective cohort study. Sex Transm Infect 2002;78:110-14